These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7967100)

  • 1. [Recent progress and trend in the development of artificial blood].
    Tsuchida E
    Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in the red cell substitutes (artificial red cells)].
    Tsuchida E
    Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial oxygen carriers, hemoglobin vesicles and albumin-hemes, based on bioconjugate chemistry.
    Tsuchida E; Sou K; Nakagawa A; Sakai H; Komatsu T; Kobayashi K
    Bioconjug Chem; 2009 Aug; 20(8):1419-40. PubMed ID: 19206516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
    Kim HW; Greenburg AG
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Artificial blood].
    Kobayashi K
    Nihon Geka Gakkai Zasshi; 2005 Jan; 106(1):31-7. PubMed ID: 15696696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modified hemoglobin solutions as artificial oxygen carriers].
    Lenz G; Bissinger U
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():63-7. PubMed ID: 7841783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposome-Encapsulated Hemoglobin, TRM-645: Current Status of the Development and Important Issues for Clinical Application.
    Kaneda S; Ishizuka T; Goto H; Kimura T; Inaba K; Kasukawa H
    Artif Organs; 2009 Feb; 33(2):146-52. PubMed ID: 19178459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of PEG-modified hemoglobin-vesicles as artificial oxygen carriers in microcirculation.
    Sakai H; Tsuchida E
    Clin Hemorheol Microcirc; 2006; 34(1-2):335-40. PubMed ID: 16543654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
    Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
    Taguchi K; Maruyama T; Otagiri M
    Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and clinical application of the artificial blood as the oxygen carriers].
    Sekiguchi S
    Nihon Rinsho; 1997 Sep; 55(9):2439-46. PubMed ID: 9301314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic carriers of oxygen.
    Dellacherie E; Labrude P; Vigneron C; Riess JG
    Crit Rev Ther Drug Carrier Syst; 1987; 3(1):41-94. PubMed ID: 3542244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
    Kim HW; Greenburg AG
    Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.
    Vlahakes GJ; Lee R; Jacobs EE; LaRaia PJ; Austen WG
    J Thorac Cardiovasc Surg; 1990 Sep; 100(3):379-88. PubMed ID: 2391974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of hemoglobin-vesicles as artificial oxygen carriers.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    Artif Organs; 2009 Feb; 33(2):139-45. PubMed ID: 19178458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluid resuscitation with artificial oxygen carriers in hemorrhaged rats: profiles of hemoglobin-vesicle degradation and hematopoiesis for 14 days.
    Sakai H; Seishi Y; Obata Y; Takeoka S; Horinouichi H; Tsuchida E; Kobayashi K
    Shock; 2009 Feb; 31(2):192-200. PubMed ID: 18520699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development and challenge of modified hemoglobins as red blood cell substitutes].
    Lu XL
    Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of enclosed hemoglobin and outer lipid component after the administration of hemoglobin vesicles as an artificial oxygen carrier.
    Taguchi K; Urata Y; Anraku M; Maruyama T; Watanabe H; Sakai H; Horinouchi H; Kobayashi K; Tsuchida E; Kai T; Otagiri M
    Drug Metab Dispos; 2009 Jul; 37(7):1456-63. PubMed ID: 19364827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemoglobin-vesicles as artificial oxygen carriers: present situation and future visions.
    Sakai H; Sou K; Horinouchi H; Kobayashi K; Tsuchida E
    J Intern Med; 2008 Jan; 263(1):4-15. PubMed ID: 18042220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive properties of synthetic blood substitutes.
    de Figueiredo LF
    Medicina (B Aires); 1998; 58(4):403-10. PubMed ID: 9816703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.